Dr. Stephan Busque, MD

Dr. Busque practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Busque's NPI, 1508891052, was assigned on July 12, 2006. Dr. Busque graduated from University of Montreal Faculty of Medicine in 1986. Dr. Busque holds California license G76050.

Dr. Busque's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Busque's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Busque to 1 more hospital and 1 medical group, each named with a free account. Dr. Busque's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Busque practices, 2 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Busque's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Busque is board certified in surgery by the American Board of Surgery. Dr. Busque is licensed in California.

Dmand AI lists kidney transplant among the conditions Dr. Busque treats.

CMS data shows 279 Medicare services from Dr. Busque across 6 procedure codes in 2024, for 86 Medicare patients. Medicare paid $90,128 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 86 Medicare patients who saw Dr. Busque in 2026. The largest group is under 65, with 62 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 60% are also on Medicaid. Their average risk score is 8.49, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Busque's median patient age at 43, with 41% women.

In 2026, Dr. Busque wrote 1,791 Medicare Part D claims for 112 patients. 85% of them were for generic drugs. CMS names the drug for 1,581 of them, across 31 drugs with 11 or more claims each, at $70,322 in total drug cost. In 2023, CMS named 1,107 claims across 28 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Busque for performance year 2026, reported as part of a group. Dr. Busque accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 60 papers to Dr. Busque, published from 2005 to 2025. 2014 was the busiest year, with 3. The most frequent topics are Kidney Transplantation, Immunosuppressive Agents and Graft Rejection. Dr. Busque has published most often in Am J Transplant. Dr. Busque's most frequent co-authors are John David Scandling, MD, Robert Lowsky, MD and Jane C. Tan, MD.

Dmand AI links Dr. Busque to 8 clinical trials, 4 of them phase 1 studies. 4 are still active or recruiting. Conditions studied include Diabetic Nephropathies, Kidney Diseases and Kidney Failure, Chronic. Stanford University sponsors the most, 5.

CMS Open Payments shows 18 general payments to Dr. Busque from 7 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 92% of the total. Grifols Shared Services North America, Inc. paid the most, $98,186.

Dmand AI lists 1 award for Dr. Busque, most recently CMS Stage 1 EHR in 2013.

Dr. Busque graduated from University of Montreal Faculty of Medicine in 1986.

Dr. Busque is in network with 10 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.